Evidence map›Paper›PMID 11487608›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2001

A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2.

G Khursigara, J Bertin, H Yano, H Moffett, P S DiStefano, M V Chao

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 171 citations in OpenAlex.

  1. Nerve growth factor receptor (NGFR): A key player in glioblastoma progression.Biochimica et biophysica acta. Reviews on cancer · 2026
    Review
  2. Review
  3. Effects of globalAging brain · 2025
    Article
  4. Article
  5. Article
  6. AraC interacts with p75Cell death & disease · 2023
    Article
  7. Review
  8. Nervous System-Driven Osseointegration.International journal of molecular sciences · 2022
    Review
  9. Review
  10. In vivo functions of p75Trends in pharmacological sciences · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

G KhursigaraWeill Medical College of Cornell University, New York, New York 10021, USA.
J Bertin
H Yano
H Moffett
P S DiStefano
M V Chao
New York University · USMillennium Engineering and Integration (United States) · USCornell University · US

Funding

TITLE REGULATION OF NEURONAL MITOSISP01HD023315 · NICHD · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI DREYFUS, CHERYL F · 1987 to 2013
$17.5M
MOLECULAR BIOLOGY OF THE NERVE GROWTH FACTOR RECEPTORR01NS021072 · NINDS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CHAO, MOSES VICTOR · 1985 to 2015
$5.8M
TUMOR NECROSIS FACTOR MECHANISM OF ACTIONR01CA056490 · NCI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CHAO, MOSES VICTOR · 1992 to 2003
$1.1M
Molecular Analysis of Neurotrophin ActionR56NS021072 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAO, MOSES VICTOR · 2011 to 2017
$882k
NCI NIH HHS CA56490NICHD NIH HHS HD23315NICHD NIH HHS P01 HD023315NINDS NIH HHS NS21072NINDS NIH HHS R01 NS021072NINDS NIH HHS R56 NS021072
6 · The paper itself

Abstract

In addition to promoting cell survival, neurotrophins also can elicit apoptosis in restricted cell types. Recent results indicate that nerve growth factor (NGF) can induce Schwann cell death via engagement of the p75 neurotrophin receptor. Here we describe a novel interaction between the p75 receptor and receptor-interacting protein 2, RIP2 (RICK/CARDIAK), that accounts for the ability of neurotrophins to choose between a survival-versus-death pathway. RIP2, an adaptor protein with a serine threonine kinase and a caspase recruitment domain (CARD), is highly expressed in dissociated Schwann cells and displays an endogenous association with p75. RIP2 binds to the death domain of p75 via its CARD domain in an NGF-dependent manner. The introduction of RIP2 into Schwann cells deficient in RIP2 conferred NGF-dependent nuclear transcription factor-kappaB (NF-kappaB) activity and decreased the cell death induced by NGF. Conversely, the expression of a dominant-negative version of RIP2 protein resulted in a loss of NGF-induced NF-kappaB induction and increased NGF-mediated cell death. These results indicate that adaptor proteins like RIP2 can provide a bifunctional switch for cell survival or cell death decisions mediated by the p75 neurotrophin receptor.

Indexed as

Activating Transcription Factor 2AnimalsApoptosisBlotting, WesternCaspasesCells, CulturedCell SurvivalCyclic AMP Response Element-Binding ProteinGenes, DominantGlutathione TransferaseGreen Fluorescent ProteinsHumansKidneyLigandsLuminescent ProteinsNerve Growth FactorActivating Transcription Factor 2CaspasesCyclic AMP Response Element-Binding ProteinGlutathione TransferaseGreen Fluorescent ProteinsLigandsLuminescent ProteinsNerve Growth FactorNF-kappa BProteinsProtein Serine-Threonine KinasesReceptor-Interacting Protein Serine-Threonine Kinase 2Receptor-Interacting Protein Serine-Threonine KinasesReceptor, Nerve Growth FactorReceptors, Nerve Growth FactorRecombinant Fusion ProteinsRIPK1 protein, humanRIPK2 protein, humanTNF Receptor-Associated Factor 6Transcription Factors

Identifiers

PMID11487608
PMCPMC6763175
OpenAlexW2103217995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.